The effect of calcitonin on β-endorphin levels in postmenopausal osteoporotic patients with back pain

Clinical Rheumatology

Volumn 26, Issue 1, 2007, Pages 44-49

  Ofluoglu, D ^a,b   Akyuz, G ^a   Unay, O ^a   Kayhan, O ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Cakmak m Soyak Yenisehir Palmiye   (Turkey)

Author keywords

endorphin; Back pain; Calcitonin; Osteoporosis; Quality of life

Indexed keywords

BETA ENDORPHIN; CALCIUM; PLACEBO; SALCATONIN;

ADULT; ARTICLE; BACKACHE; BLOOD SAMPLING; BONE FRAGILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FRACTURE; HUMAN; IMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; PAIN ASSESSMENT; PATIENT SATISFACTION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VISUAL ANALOG SCALE;

AGED; BACK PAIN; BETA-ENDORPHIN; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCITONIN; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PLACEBOS; QUALITY OF LIFE; SINGLE-BLIND METHOD;

EID: 33845895527     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0228-z     Document Type: Article

References (18)

1. Sinaki M (2000) Prevention and treatment of osteoporosis. In: Braddom R, Buschbcher RM, Dumitru D, Johnson EW, Matthews D, Sinaki M (eds) Physical medicine and rehabilitation. Saunders, Philadelphia, PA, pp 895-912
2. Devogelaer JP (1998) A risk benefit assessment of alendronate in the treatment of involutional osteoporosis. Drug Saf 19(2):141-154
3. Kanis JA, Delmas P, Burckhardt P et al (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7:390-406
4. Pun KK, Chan LWL (1989) Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther 11(2):205-209
5. Civitelli R (1996) Calcitonin. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic, San Diego, CA, pp 1235-1253
6. Franceschini R, Cataldi A, Barreca T et al (1989) Plasma beta-endorphin, ACTH and cortizol secretion in man after nasal spray administration of calcitonin. Eur J Clin Pharmacol 37:341-343
7. Kucukdeveci AA, McKenna SP, Kutlay S et al (2000) The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 23(1):31-38
8. Lyritis GP, Ioannidis GV, Karachalios T et al (1999) Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: A prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain 15(4):284-289
9. Lyritis GP, Tsakalakos N, Magiasis B et al (1991) Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled study. Calcif Tissue Int 49:369-372
10. Lyritis GP, Ioannidis P, Karachalios T et al (1997) Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study. Acta Orthop Scand (Suppl 275)68:112-114
11. Pontiroli AE, Pajetta E, Scaglia L et al (1994) Analgesic effect of intranasal and intramuscular salmon calcitonin in postmenopausal osteoporosis: A double-blind, double-placebo study. Aging 6(6):459-463
12. Orne MT, Whitehouse WG (1998) Nonpharmacological approaches to pain relief: Hypnosis, self-hypnosis, placebo effects. In: Aronoff GM (ed) Evaluation and treatment of chronic pain. Williams & Wilkins, Baltimore, MD, p 579
13. Cesarani F, Colombo M, Olgiati VR et al (1979) Calcitonin and prostaglandin system. Life Sci 25:1851-1856
14. Maeda Y, Yamada K, Hasegawa T et al (1994) Relationship between anti-aversive effects of salmon calcitonin and plasma levels of ACTH, beta-endorphin and Prostaglandin-E2 in mice. Res Commun Chem Pathol Pharmacol 83(1):15-24
15. Wang XS, Mendoza TR, Gao SZ et al (1994) The Chinese version of the Brief Pain Inventory (BPI-C): Its development and use in a study of cancer pain. Pain 67:407-416
16. Laurain L, Oberman Z, Hoere E et al (1988) Antiserotoninergic inhibition of calcitonin-induced increase of beta-endorphin, ACTH and cortisol secretion. J Neural Transm 73:167-176
17. Mystakidou K, Befon S, Hondros K et al (1999) Continous subcutaneous administration of high-dose salmon calcitonin in bone metastasis: Pain control and beta-endorphin plasma levels. J Pain Symptom Manage 18(5):323-330
18. Papadokostakis G, Damilakis J, Mantzouranis E et al (2005) The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis. Eur Spine J (29) (Epub ahead of print)